0      0

AONN+ Annual 2020

THURS08 - Industry Sponsored Session | Don't Delay! Act Now! Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine (non-CE) Presentation by Wellstat

Nov 5, 2020 4:30pm ‐ Nov 5, 2020 5:45pm


Program Objectives:

  • Describe the incidence and burden of early-onset severe toxicity in patients receiving 5-FU and capecitabine
  • Describe mechanism of action of 5-FU and its cytotoxic metabolites as it relates to the causes of early-onset severe toxicity
  • Recognize signs and symptoms of 5-FU and capecitabine early-onset severe toxicity
  • Summarize evidence supporting emergency treatment for patients with early-onset severe toxicity and following 5-FU and capecitabine overdoses
  • Review the importance of prompt treatment of overdoses and early-onset severe toxicity
  • Educate patients, caregivers, and colleagues about the importance of recognizing and urgently treating early-onset severe toxicity of 5-FU and capecitabine


  • Alice Beers, BSN, OCN, NPD-BC, Oncology Nurse Navigator, MedStar Georgetown Cancer Network at Washington Cancer Institute MedStar Washington Hospital Center

You must be logged in and own this session in order to post comments.